Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.

Sci Rep · 2021 · PMC8065122 · PMID 33893375

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

1 B; p = 0.003), and high EFNA5 also showed a trend to shorter time to recurrence/PFS (Fig. 1 C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.